Literature DB >> 34413943

Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34413943      PMCID： PMC8365614          DOI： 10.1021/acsmedchemlett.1c00356

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Medical, Surgical, and Genetic Treatment of Huntington Disease.

Authors:  Christine M Stahl; Andrew Feigin
Journal:  Neurol Clin       Date:  2020-03-09       Impact factor: 3.806

Review 2.  Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Pei Teng Lum; Mahendran Sekar; Siew Hua Gan; Srinivasa Reddy Bonam; Mohd Farooq Shaikh
Journal:  ACS Chem Neurosci       Date:  2021-01-21       Impact factor: 4.418

Review 3.  Striatal circuit development and its alterations in Huntington's disease.

Authors:  Margaux Lebouc; Quentin Richard; Maurice Garret; Jérôme Baufreton
Journal:  Neurobiol Dis       Date:  2020-09-06       Impact factor: 5.996

Review 4.  In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease.

Authors:  Harleen Kohli; Pravir Kumar; Rashmi K Ambasta
Journal:  Heliyon       Date:  2021-02-12

Review 5.  Irritability in Huntington's Disease.

Authors:  Nicholas E Karagas; Natalia Pessoa Rocha; Erin Furr Stimming
Journal:  J Huntingtons Dis       Date:  2020

Review 6.  Therapeutic Advances for Huntington's Disease.

Authors:  Ashok Kumar; Vijay Kumar; Kritanjali Singh; Sukesh Kumar; You-Sam Kim; Yun-Mi Lee; Jong-Joo Kim
Journal:  Brain Sci       Date:  2020-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.